Merck & Co Inc (MRK)

MRK on New York Consolidated

62.09USD
29 Jan 2015
Change (% chg)

$0.64 (+1.04%)
Prev Close
$61.45
Open
$61.54
Day's High
$62.15
Day's Low
$60.76
Volume
9,091,286
Avg. Vol
10,526,670
52-wk High
$63.62
52-wk Low
$51.78

MRK

Chart for MRK

About

Merck & Co., Inc. is a health care company that offers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company’s operations are comprised of four operating segments, which are the Pharmaceut... (more)

Overall

Beta: 0.34
Market Cap(Mil.): $175,186.20
Shares Outstanding(Mil.): 2,850.87
Dividend: 0.45
Yield (%): 2.93

Financials

  MRK Industry Sector
P/E (TTM): 33.68 39.93 40.74
EPS (TTM): 1.82 -- --
ROI: 6.72 18.93 18.19
ROE: 11.63 19.71 19.08
Search Stocks

Europe recommends seven new medicines for approval

LONDON - Europe recommended seven new drugs for approval on Friday, including two antibiotics for skin infections and a new treatment option for HIV.

23 Jan 2015

Europe recommends seven new medicines for approval

LONDON, Jan 23 - Europe recommended seven new drugs for approval on Friday, including two antibiotics for skin infections and a new treatment option for HIV.

23 Jan 2015

Johnson & Johnson's forex warning a sign for rival drugmakers

- Johnson & Johnson surprised investors by detailing the degree to which a strong dollar will hurt sales abroad this year, and industry watchers say Wall Street is underestimating the likely hit to other U.S.-based rivals such as Pfizer Inc and Merck & Co .

20 Jan 2015

Johnson & Johnson's forex warning a sign for rival drugmakers

Jan 20 - Johnson & Johnson surprised investors by detailing the degree to which a strong dollar will hurt sales abroad this year, and industry watchers say Wall Street is underestimating the likely hit to other U.S.-based rivals such as Pfizer Inc and Merck & Co.

20 Jan 2015

Exclusive: Merck funds tests of lower Zilmax doses as seen seeking way to resume sales

CHICAGO - Merck & Co Inc is funding the testing of lower dosages of its controversial cattle growth drug Zilmax, in a move that livestock experts say is crucial if the company is to resume sales of the product to the U.S. beef industry.

19 Jan 2015

Lilly to test combinations with Merck, Bristol-Myers' cancer drugs

- Eli Lilly & Co signed two separate deals with Merck & Co Inc and Bristol-Myers Squibb Co to test combinations of its cancer treatments with two recently approved therapies that belong to a promising new class of drugs.

13 Jan 2015

Lilly to test combinations with Merck, Bristol-Myers' cancer drugs

Jan 13 - Eli Lilly & Co signed two separate deals with Merck & Co Inc and Bristol-Myers Squibb Co to test combinations of its cancer treatments with two recently approved therapies that belong to a promising new class of drugs.

13 Jan 2015

Merck, Bristol heat up immunotherapy race in lung cancer

- Bristol-Myers Squibb and Merck & Co broke further away from rival drugmakers in the race to treat lung cancer with a new generation of immune system therapies, adding pressure on the likes of Roche and AstraZeneca to play catch-up.

12 Jan 2015

Merck, Bristol heat up immunotherapy race in lung cancer

Jan 12 - Bristol-Myers Squibb and Merck & Co broke further away from rival drugmakers in the race to treat lung cancer with a new generation of immune system therapies, adding pressure on the likes of Roche and AstraZeneca to play catch-up.

12 Jan 2015

Merck speeds up drug-submission plans for Hep C, lung cancer

- Merck & Co said it would fast track its plans to submit new drugs for hepatitis C and lung cancer for regulatory approval.

12 Jan 2015

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks